Gynecologic Cancer News

The FDA granted fast track designation to XMT-1536 for the treatment of women with high-grade serous ovarian cancer, according to a press release from the agent’s manufacturer.

Consumption of caffeinated coffee does not appear to increase risk for various cancer types, according to a review article published in The New England Journal of Medicine.

The addition of trastuzumab to carboplatin and paclitaxel increased PFS and OS for women with advanced or recurrent HER2-positive uterine serous carcinoma, according to final results of a phase 2 study published in Clinical Cancer Research.

Expansion of Medicaid under the Affordable Care Act appeared associated with a reduction in critical cancer outcome disparities among adults residing in low-income communities in Ohio, according to study results published in Cancer.

An updated guideline issued by the American Cancer Society recommends cervical cancer screening with the HPV test every 5 years from age 25 years to 65 years.

Women who underwent chemotherapy or surgery for gynecologic cancer and also had COVID-19 infection did not appear at significantly increased risk for death due to the novel coronavirus, according to study findings published in Cancer.

Members of the American Society for Radiation Oncology elected four new officers to the organization’s board of directors.

Cancer can be a very personal and individualized disease, with predictable and unpredictable outcomes.

Immunotherapy did not appear to worsen complications among patients with cancer and COVID-19, according to results of a study presented at American Association for Cancer Research Virtual Meeting: COVID-19 and Cancer.

Roswell Park Comprehensive Caner Center appointed three staff members within its department of gynecologic oncology to leadership roles.